Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial

• Rakesh Popat,
• Dana Warcel,
• Jenny O’Nions,
• Anna Cowley,
• Sasha Smith,
• William R Tucker,
• Kwee Yong,
• Simona Degli Esposti

Affiliations

Rakesh Popat

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

Dana Warcel

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

Jenny O’Nions

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

Anna Cowley

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

Sasha Smith

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

William R Tucker

National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK

Kwee Yong

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust

Simona Degli Esposti

National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK